Drug-Drug Interaction Module—FDA-Label Powered, Terminal-Ready—Now Live in All Open Models

PGxAI has released a new Drug-Drug Interaction (DDI) engine that mines structured information directly from FDA prescription-label sections. The module screens any two (or more) compounds for clinically significant interactions and delivers risk-tiered guidance in real time. Even the open, terminal-only versions of our models now support instant DDI queries—simply load the CLI, enter drug names, and receive evidence-linked warnings in under a second. Enterprise users can enable the same logic via our REST API for seamless EHR integration.

Ready for deeper integration or high-throughput analysis? Reach out via our contact form—we’re here to help.